- Home
- Johnson & Johnson
Johnson & Johnson
Cancer scientist Lewis Cantley, Ph.D., wins the 2020 Dr. Paul Janssen Award for biomedical research
Cancer. Diabetes. Autoimmune diseases. They’re the common illnesses we have a better chance at fighting, thanks to Dr. Cantley’s pioneering work. Learn more about his “magic molecule” research.
Johnson & Johnson signs a historic pledge to uphold the integrity of the scientific process in developing an investigational COVID-19 vaccine
In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
4 innovative ways Johnson & Johnson has helped protect the public’s health during outbreaks since the late 1800s
From epidemic masks that the company introduced during the Spanish flu pandemic to work it’s doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.
Johnson & Johnson named to Fast Company‘s 2020 Best Workplaces for Innovators list
The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company’s culture.
5 questions for a scientist who’s working to uncover new treatments for psoriatic arthritis
Early in his career Daniel Cua, Ph.D., made a discovery that would lead to a new medication for the debilitating autoimmune disease. We sat down with Dr. Cua, known as “the father” in his field of study, to learn what his work could mean for those with psoriatic arthritis.
Quiz: How much do you really know about taking care of your eyes?
Around the world, more than 1 billion people have impaired vision—but 80% of these cases are preventable with early diagnosis and treatment. Ready to test your eye IQ with our quiz?
6 top questions about COVID-19: What a child psychiatrist has to say
On the latest episode of The Road to a Vaccine, host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
What you need to know about Johnson & Johnson’s 2020 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
“I was working on a potential COVID-19 vaccine—Then my wife got sick”: Meet a researcher whose personal experience is fueling his fight against the pandemic
Within a matter of weeks, Ramon Polo’s work and home life were completely changed by the novel coronavirus—and he’s a stronger scientist and husband for it.
Chairman and CEO Alex Gorsky discusses Johnson & Johnson’s response to COVID-19 at the Fortune Brainstorm Health Conference
Watch a video of Gorsky’s interview at the virtual summit, which includes the latest information on the company’s pursuit of a potential COVID-19 vaccine.